Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada.
Amphotericin B in its lipid formulation continues to be the reference drug in the treatment of systemic fungal infections despite the time elapse since the development of this compound. The absence of fungal resistance, pharmacokinetics, and the better tolerability profile as compared with the remai...
| Main Authors: | , |
|---|---|
| Formato: | info:eu-repo/semantics/article |
| Idioma: | spa |
| Publicado: |
Sociedad Espanola de Quimioterapia
2012
|
| Subjects: | |
| Acceso en liña: | https://hdl.handle.net/10171/22324 |